Monoterapia rytuksymabem w pęcherzycy liściastej
Introduction. Rituximab is a chimeric human-mouse monoclonal antibody,which binds to the CD20 antigen on B and pre-B lymphocytesand causes depletion of CD20+ cells in the mechanism of complement-dependent and independent cytolysis, antibody-dependent cell cytotoxicityand the mechanism of apoptosis....
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Termedia Publishing House,
2011-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|